Literature DB >> 14592194

Amnestic sleep-related eating disorder associated with zolpidem.

Timothy I Morgenthaler1, Michael H Silber.   

Abstract

OBJECTIVE: To describe the association of amnestic nocturnal eating behavior with use of zolpidem for insomnia.
BACKGROUND: Sleep-related eating disorder is increasingly recognized in relationship to other diagnosable sleep disorders. Many of these disorders, like restless legs syndrome (RLS), give rise to complaints of insomnia. Zolpidem is the most commonly prescribed drug for insomnia complaints, and although it has sometimes been associated with side effects of transient amnesia and sleep walking, an association with sleep-related eating has not been previously emphasized.
METHODS: Consecutive case series of five patients who were using zolpidem and evaluated with nocturnal eating behaviors.
RESULTS: We evaluated five patients over 11 months with problematic amnestic nocturnal eating associated with zolpidem used for complaints of insomnia. All five patients had RLS, three had obstructive sleep apnea syndrome, two had sleep walking, and one had psychophysiologic insomnia. With discontinuation of zolpidem and effective treatment of their sleep disorders, nocturnal eating resolved.
CONCLUSIONS: Zolpidem, at least in patients with underlying sleep disorders that cause frequent arousals, may cause or augment sleep-related eating behavior. This report demonstrates the importance of arriving at a specific diagnosis for insomnia complaints, and alerts the sleep practitioner to this unusual side effect of zolpidem.

Entities:  

Year:  2002        PMID: 14592194     DOI: 10.1016/s1389-9457(02)00007-2

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  42 in total

1.  Sleep-related eating disorders.

Authors:  R Robert Auger
Journal:  Psychiatry (Edgmont)       Date:  2006-11

2.  Adverse reactions to zolpidem: case reports and a review of the literature.

Authors:  Takuji Inagaki; Tsuyoshi Miyaoka; Seiichi Tsuji; Yasushi Inami; Akira Nishida; Jun Horiguchi
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

3.  Long-term follow-up of patients with insomnia.

Authors:  Leon D Rosenthal; Diana C Dolan; Daniel J Taylor; Emily Grieser
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-07

4.  Report of two cases where sleep related eating behavior occurred with the extended-release formulation but not the immediate-release formulation of a sedative-hypnotic agent.

Authors:  Ambrose Chiang; Andrew Krystal
Journal:  J Clin Sleep Med       Date:  2008-04-15       Impact factor: 4.062

Review 5.  Development of criteria for a diagnosis: lessons from the night eating syndrome.

Authors:  Albert J Stunkard; Kelly C Allison; Allan Geliebter; Jennifer D Lundgren; Marci E Gluck; John P O'Reardon
Journal:  Compr Psychiatry       Date:  2008-11-26       Impact factor: 3.735

6.  Sleep self-intoxication and sleep driving as rare zolpidem-induced complex behaviour.

Authors:  Alexander Paulke; Cora Wunder; Stefan W Toennes
Journal:  Int J Legal Med       Date:  2014-04-27       Impact factor: 2.686

7.  Zolpidem and amnestic sleep related eating disorder.

Authors:  Muhammad Najjar
Journal:  J Clin Sleep Med       Date:  2007-10-15       Impact factor: 4.062

Review 8.  Hypnosedative-induced complex behaviours : incidence, mechanisms and management.

Authors:  Christian R Dolder; Michael H Nelson
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  Two Cases of Sleep-Related Eating Disorder Responding Promptly to Low-Dose Sertraline Therapy.

Authors:  Ranji Varghese; Jorge Rey de Castro; Cesar Liendo; Carlos H Schenck
Journal:  J Clin Sleep Med       Date:  2018-10-15       Impact factor: 4.062

Review 10.  Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem.

Authors:  Romy Hoque; Andrew L Chesson
Journal:  J Clin Sleep Med       Date:  2009-10-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.